Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.

Bonaventura CasanovaLaura Lacruz BallesterMaría Luisa VillarJosé Andrés DomínguezMaría Carcelén GadeaFrancisco GascónJavier MalladaDavid HervásMaría Simó-CastellóJosé Carlos Álvarez-CermeñoCarmen CallesJavier OlascoagaLluís Ramió-TorrentàCarmen AlcaláAngeles CervellóIsabel BoscáFrancisco Carlos Pérez-MiralllesFrancisco Coret

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2018)

OCMB in CSF could be a biomarker of treatment response in multiple sclerosis.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
white matter
peritoneal dialysis
prognostic factors
dendritic cells